← Gildan Activewear overview

Gildan Activewear vs Hermes International SCA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Gildan Activewear Inc. (GIL)

Q3 2026
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

July 2026
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

Latest
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

Q2 2026
▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

June 2026
▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

Hermes International SCA (RMS.PA)

Q3 2026
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.

July 2026
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.

Latest
▼3▲1

Hermès beats on earnings but China worries and Kering's rebound drag shares

  • Strong first-half results Hermès reported first-half revenue of €8.2 billion, up 6% at constant currencies, with a 41% operating margin and €2.2 billion free cash flow. All regions grew except the Middle East, and the company confirmed its medium-term growth goal. This solid performance supports the stock's value.

    This is the core fundamental news that reassures investors about Hermès' financial health.

  • Kering's Gucci turnaround pressures luxury peers Kering shares jumped 15% as Gucci's sales decline was less severe than feared, prompting analyst upgrades. This shift in market sentiment led to a rotation out of Hermès, which fell over 12% as investors anticipated a normalization of its growth rates. Competition is intensifying.

    It explains a key reason for Hermès' sharp share price drop despite good earnings.

  • China recovery remains elusive Hermès shares slumped 11% amid no signs of recovery in the Chinese market, a crucial region for luxury goods. This persistent weakness raises concerns about future demand and growth prospects, overshadowing the company's otherwise strong first-half performance.

    It highlights a major geographic risk that is currently weighing on the stock.

  • Valuation concerns after earnings Following the earnings report, Hermès stock closed at €1,550.50, about 3% above a narrative fair value of €1,505. With shares down 26% year-to-date, the valuation remains in focus, and unresolved issues like the missing €14 billion share saga add uncertainty.

    It shows that even with strong results, the stock may be overvalued, limiting upside.

© 2026 MarketDXWhy